Abstract: The invention relates to a façade element which is suitable to mount on the outside (3) of a building (2). According to the invention plate shaped façade elements (5, 51 . . . ) consisting of glass fibre reinforced plastics, and which exhibit a wooden structure (6, 61 . . . ) on its outwards (7) turnable side (8, 81 . . . ) and which externally have the shape of standing and/or lying panels (9, 91 . . . ), are arranged to be mounted next to one another and attached to the wall (10) in question, to form a façade facing for the building (2) in question. The invention also relates to a procedure for manufacturing of the façade elements (5, 51 . . . ).

Abstract: The invention refers to method for selectively binding and separating at least one component from whole blood or a body fluid, whereby the blood or body fluid is allowed to pass through a rigid integral separation matrix without being excluded therefrom. The matrix has a porous structure with a pore size ranging from 5 micron to 500 micron as well as an active surface ranging from 0.5 cm2 to 10 m2, and the surface is able to bind such components.

Abstract: The invention refers to method for selectively binding and separating at least one component from whole blood or a body fluid, whereby the blood or body fluid is allowed to pass through a rigid integral separation matrix without being excluded therefrom. The matrix has a porous structure with a pore size raging from 5 micron to 500 micron as well as an active surface ranging from 0.5 cm2 to 10 m2, and the surface is able to bind such components.

Abstract: The invention refers to method for selectively binding and separating at least one component from whole blood or a body fluid, whereby the blood or body fluid is allowed to pass through a rigid integral separation matrix without being excluded therefrom. The matrix has a porous structure with a pore size ranging from 5 micron to 500 micron as well as an active surface ranging from 0.5 cm2 to 10 m2, and the surface is able to bind such components.

Abstract: The invention refers to method for selectively binding and separating at least one component from whole blood or a body fluid, whereby the blood or body fluid is allowed to pass through a rigid integral separation matrix without being excluded therefrom. The matrix has a porous structure with a pore size raging from 5 micron to 500 micron as well as an active surface ranging from 0.5 cm2 to 10 m2, and the surface is able to bind such components.

Abstract: The invention refers to method for selectively binding and separating at least one component from whole blood or a body fluid, whereby the blood or body fluid is allowed to pass through a rigid integral separation matrix without being excluded therefrom. The matrix has a porous structure with a pore size ranging from 5 micron to 500 micron as well as an active surface ranging from 0.5 cm2 to 10 m2, and the surface is able to bind such components.

Abstract: A composition and method for coating medical devices is provided. One embodiment of the present invention employs a coating composition comprising hyaluronic acid and heparin. Another embodiment of the present invention employs a coating composition comprising poly-lysine and heparin. Yet another embodiment of the present invention employs a coating composition comprising hirudin, a peptide and heparin.